DOI QR코드

DOI QR Code

Altered expression of norepinephrine transporter and norepinephrine in human placenta cause pre-eclampsia through regulated trophoblast invasion

  • Na, Kyu-Hwan (Department of Biomedical Science, CHA University) ;
  • Choi, Jong Ho (Department of Biomedical Science, CHA University) ;
  • Kim, Chun-Hyung (Molecular Neurobiology Lab, McLean Hospital, Harvard Medical School) ;
  • Kim, Kwang-Soo (Molecular Neurobiology Lab, McLean Hospital, Harvard Medical School) ;
  • Kim, Gi Jin (Department of Biomedical Science, CHA University)
  • Received : 2013.01.12
  • Accepted : 2013.03.14
  • Published : 2013.03.31

Abstract

Objective: We investigated the norepinephrine transporter (NET) expression in normal and pre-eclamptic placentas and analyzed the invasion activity of trophoblastic cells based on norepinephrine (NE)-NET regulation. Methods: NET and NE expression levels were examined by western blot and enzyme-linked immunosorbent assay, respectively. Trophoblast invasion activity, depending on NE-NET regulation, was determined by NET-small interfering RNA (siRNA) and NET transfection into the human extravillous trophoblast cells with or without NE treatment and invasion rates were analyzed by zymography and an invasion assay. Results: NET mRNA was expressed at a low level in pre-eclamptic placentas compared with normal placentas and NE concentration in maternal plasma increased significantly in pre-eclamptic women compared to normal pregnant women (p<0.05). NET gene upregulation and NE treatment stimulated trophoblast cell invasion up to 2.5-fold (p<0.05) by stimulating matrix metalloproteinase-9 activity via the phosphoinositol-3-kinase/AKT signaling pathway, whereas NET-siRNA with NE treatment reduced invasion rates. Conclusion: NET expression is reduced by inadequate regulation of NE levels during placental development. This suggests that a complementary balance between NET and NE regulates trophoblast cell invasion activities during placental development.

Keywords

References

  1. Maynard SE, Karumanchi SA, Thadhani R. Hypertension and kidney disease in pregnancy. In: Brenner BM, editor. Brenner & Rector's the kidney. 8th ed. Philadelphia: Saunders; 2008. p. 1567-95.
  2. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6. https://doi.org/10.1016/S0140-6736(00)03577-7
  3. Benischke K, Kaufmann P. Pathology of the human placenta. 4th ed. New York: Springer-Verlag; 2000.
  4. Ilekis JV, Reddy UM, Roberts JM. Preeclampsia: a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007;14:508-23. https://doi.org/10.1177/1933719107306232
  5. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4. https://doi.org/10.1016/0002-9378(89)90665-0
  6. Manyonda IT, Slater DM, Fenske C, Hole D, Choy MY, Wilson C. A role for noradrenaline in pre-eclampsia: towards a unifying hypothesis for the pathophysiology. Br J Obstet Gynaecol 1998; 105:641-8. https://doi.org/10.1111/j.1471-0528.1998.tb10179.x
  7. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia: a state of sympathetic overactivity. N Engl J Med 1996; 335:1480-5. https://doi.org/10.1056/NEJM199611143352002
  8. Mao W, Qin F, Iwai C, Vulapalli R, Keng PC, Liang CS. Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells. Am J Physiol Heart Circ Physiol 2004; 287:H29-39. https://doi.org/10.1152/ajpheart.01168.2003
  9. Ramamoorthy S, Prasad PD, Kulanthaivel P, Leibach FH, Blakely RD, Ganapathy V. Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. Biochemistry 1993;32:1346-53. https://doi.org/10.1021/bi00056a021
  10. Hayer-Zillgen M, Bruss M, Bonisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 2002;136:829-36. https://doi.org/10.1038/sj.bjp.0704785
  11. Bzoskie L, Blount L, Kashiwai K, Tseng YT, Hay WW Jr, Padbury JF. Placental norepinephrine clearance: in vivo measurement and physiological role. Am J Physiol 1995;269:E145-9.
  12. Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslen B, Marsal K, et al. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 2004;25:518-29. https://doi.org/10.1016/j.placenta.2003.10.017
  13. Kaaja RJ, Leinonen A, Moore P, Yandle T, Frampton CM, Nicholls MG. Effect of changes in body posture on vasoactive hormones in pre-eclamptic women. J Hum Hypertens 2004;18:789-94. https://doi.org/10.1038/sj.jhh.1001743
  14. Moisey DM, Tulenko T. Increased sensitivity to angiotensin in uterine arteries from pregnant rabbits. Am J Physiol 1983;244: H335-40.
  15. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991;98:648-55. https://doi.org/10.1111/j.1471-0528.1991.tb13450.x
  16. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006;12:369-75. https://doi.org/10.1158/1078-0432.CCR-05-1698
  17. Guo K, Ma Q, Wang L, Hu H, Li J, Zhang D, et al. Norepinephrineinduced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep 2009;22:825-30.
  18. Dong E, Yatani A, Mohan A, Liang CS. Myocardial beta-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity. Eur J Pharmacol 1999;384:17-24. https://doi.org/10.1016/S0014-2999(99)00652-4
  19. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 1993;206:204-11. https://doi.org/10.1006/excr.1993.1139
  20. Kim CH, Hwang DY, Park JJ, Kim KS. A proximal promoter domain containing a homeodomain-binding core motif interacts with multiple transcription factors, including HoxA5 and Phox2 proteins, and critically regulates cell type-specific transcription of the human norepinephrine transporter gene. J Neurosci 2002; 22:2579-89.
  21. Fu J, Chen Y, Cao J, Luo T, Qian YW, Yang W, et al. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1alpha pathways. Hepatology 2011;53:181-92. https://doi.org/10.1002/hep.24015
  22. Yu T, Wu Y, Helman JI, Wen Y, Wang C, Li L. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Mol Cancer Res 2011;9:161-72. https://doi.org/10.1158/1541-7786.MCR-10-0386
  23. Spessotto P, Bulla R, Danussi C, Radillo O, Cervi M, Monami G, et al. EMILIN1 represents a major stromal element determining human trophoblast invasion of the uterine wall. J Cell Sci 2006;119: 4574-84. https://doi.org/10.1242/jcs.03232
  24. Roberts JM, Von Versen-Hoeynck F. Maternal fetal/placental interactions and abnormal pregnancy outcomes. Hypertension 2007;49:15-6. https://doi.org/10.1161/01.HYP.0000251523.44824.02
  25. Moore KL, Persaud. TV. The developing human-clinically orientated embryology. 8th ed. Potland: Elsvier Saunders; 2008.
  26. Kawamura K, Kawamura N, Sato W, Fukuda J, Kumagai J, Tanaka T. Brain-derived neurotrophic factor promotes implantation and subsequent placental development by stimulating trophoblast cell growth and survival. Endocrinology 2009;150:3774-82. https://doi.org/10.1210/en.2009-0213
  27. Cudihy D, Lee RV. The pathophysiology of pre-eclampsia: current clinical concepts. J Obstet Gynaecol 2009;29:576-82. https://doi.org/10.1080/01443610903061751
  28. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 1997;17:8451-8.
  29. Ganapathy V, Ramamoorthy S, Leibach FH. Transport and metabolism of monoamines in the human placenta: a review. Placenta 1993;14:35-51. https://doi.org/10.1016/S0143-4004(05)80281-4
  30. Jayanthi LD, Prasad PD, Ramamoorthy S, Mahesh VB, Leibach FH, Ganapathy V. Sodium- and chloride-dependent, cocainesensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter. Biochemistry 1993;32:12178-85. https://doi.org/10.1021/bi00096a030
  31. Mao W, Iwai C, Qin F, Liang CS. Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress. Am J Physiol Heart Circ Physiol 2005;288:H2381-9. https://doi.org/10.1152/ajpheart.00904.2004
  32. Yu S, Wong SL, Lau CW, Huang Y, Yu CM. Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells. Biochem Biophys Res Commun 2011;407:44-8. https://doi.org/10.1016/j.bbrc.2011.02.096
  33. Fisher SJ, Leitch MS, Kantor MS, Basbaum CB, Kramer RH. Degradation of extracellular matrix by the trophoblastic cells of firsttrimester human placentas. J Cell Biochem 1985;27:31-41. https://doi.org/10.1002/jcb.240270105

Cited by

  1. Hypertensive emergencies: a new clinical approach vol.21, pp.None, 2015, https://doi.org/10.1186/s40885-015-0027-4
  2. Gestational stress, placental norepinephrine transporter and offspring fertility vol.153, pp.2, 2017, https://doi.org/10.1530/rep-16-0312
  3. A Comparative Study of Bolus Norepinephrine, Phenylephrine, and Ephedrine for the Treatment of Maternal Hypotension in Parturients with Preeclampsia During Cesarean Delivery Under Spinal Anesthesia vol.25, pp.None, 2013, https://doi.org/10.12659/msm.914143
  4. Dopamine in the Pathophysiology of Preeclampsia and Gestational Hypertension: Monoamine Oxidase (MAO) and Catechol-O-methyl Transferase (COMT) as Possible Mechanisms vol.2019, pp.None, 2013, https://doi.org/10.1155/2019/3546294